Business

February 25, 2014 10:58 AM

FDA to review BioCryst's flu treatment

Durham drug developer BioCryst says federal regulators have accepted Peramivir for safety review.

Related content

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Raleigh Top Jobs

View All Top Jobs